Diploma of Diagnostic Ultrasound
Certification in Maternal Fetal Medicine
Certification in Obstetric and Gynaecological Ultrasound
Master of Business Administration
Fergus Scott is an obstetrician and gynaecologist, with sub-specialist qualifications in Maternal Fetal Medicine and Obstetric and Gynaecological Imaging (COGU). Working at Sydney Ultrasound for Women and in the Imaging Department at The Royal Hospital for Women, Prince of Wales Campus, Randwick. This appointment is combined with being an Associate Professor with UNSW.
Main areas of interest include prenatal diagnosis and the changing paradigms within early pregnancy screening, particularly with first trimester ultrasound (nuchal translucency), non-invasive prenatal testing, as well as diagnostic testing using CVS and amniocentesis with SNP-array analysis.
Other professional associations have included:
President Australiasian Society for Ultrasound in Medicine / Board member of the World Federation of Ultrasound in Medicine and Biology
Chair COGU sub-specialty committee, chair of the COGU exam
Main areas of interest include: Prenatal Diagnosis, Prenatal screening for genetic and structural abnormalities (particularly involving NIPT and first trimester ultrasound), 3/4D ultrasound
Publications sine 2013:
F. Scott, K. Murphy, L. Carey, W. Greville, N. Mansfield, P. Barahona, R. Robertson and A. McLennan. Prenatal diagnosis using combined quantitative fluorescent polymerase chain reaction and array comparative genomic hybridization analysis as a first-line test: results from over 1000 consecutive cases. Ultrasound Obstet Gynecol 2013; 41: 500-507.
Carey L, Scott F, Murphy K, Mansfield N, Barahona P, Leigh, D, Robertson R and McLennan A. Prenatal diagnosis of chromosomal mosaicism in over 1600 cases using array comparative genomic hybridization as a first line test. Prenat. Diagn. 2014; 34: 478-486.
McLennan A., Palma-Dias R., Da Silva Costa F., Meagher S., Nisbet D., Scott F. Noninvasive prenatal testing in routine clinical practice – An audit of NIPT and combined first-trimester screening in an unselected Australian population. ANZJOG 2016; 56: 22-28.
Scott F, Menezes M, Palma-Dias R, Nisbet D, Schluter P, da Silva Costa F, McLennan A. Factors affecting cell-free DNA fetal fraction and the consequences for test accuracy. J Matern Fetal Neonatal Med 2018 Jul;31(14):1865-1872.
Kornman L, Palma-Dias R, Nisbet D, Scott F, Menezes M, da Silva Costa F, McLennan A. Non-Invasive Prenatal Testing for Sex Chromosome Aneuploidy in Routine Clinical Practice. Fetal Diagn Ther. 2018; 44: 85–90.
Scott F, Richardson E, McLennan A. Discordance identification following non-invasive prenatal testing. Prenatal diagnosis 2017; 37: 1298-1304.
Scott F, Sandow R, Bonnifaccio M, Ellis K, E Smet, McLennan A. Rare autosomal trisomies; important and not so rare. Prenatal diagnosis 2018; 10: 765-771.
Smet E, Scott F, McLennan A. Discordant fetal sex on NIPT and ultrasound. Prenatal Diagnosis 2020; 40 (11): 1353-65. (Invited review article)
Sandow R, Scott F, Schluter PJ, Rolnik D, Menezes M, Nisbet D, McLennan A. Increasing maternal age is not a significant cause of false positive results for Monosomy X in non-invasive prenatal testing Prenatal Diagnosis 2020; 40:1466-73.
Scott F, Smet E, Hardy T, Sundercombe S, Friedlander M, Kirk E, Carey L, Li B, McLennan A. Concurrent Maternal Malignancy and Fetal Trisomy Detected Using Genome-Wide Noninvasive Prenatal Screening. Prenatal Diagnosis 2021;41(10):1273-6.
Scott F, Menezes M, Smet M, Carey K, Hardy T, Fullston T, Rolnik D, McLennan A. Influence of fibroids on cfDNA screening accuracy. Ultrasound in Obstet Gynecol 2022;59:114-9.